U.S., Sept. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07824050) titled 'Analysis of Life-threatening ARrhythMias After Acute Coronary Syndrome' on Sept. 11.
Brief Summary: Patients admitted with an acute coronary syndrome (ACS) are at increased risk of malignant cardiac arrhythmias (MA), such as sustained ventricular tachycardia and ventricular fibrillation. Therefore, patients with ST-elevation myocardial infarction (STEMI) are continuously monitored for a minimum of 24 hours after onset symptoms. Longer monitoring is advised in patients at intermediate to high risk of cardiac arrhythmias, however this risk stratification is not evidence based. Hospitalization, particularly in STEMI patients, is advis...